Atlas Trials

Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy Volunteers

Clinical trial NCT01563432 · COMPLETED

Trial details

NCT number
NCT01563432
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gout
Start date
2012-01-01
Primary completion
2012-02-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.